Nico Trummer
7 Papers
Nico Trummer is an academic researcher. The author has contributed to research in topics: Medicine & Biology. The author has co-authored 3 publications.
Chat about Author
Papers
Drugst.One - A plug-and-play solution for online systems medicine and network-based drug repurposing
Andreas Maier,Michael Hartung,Mark Abovsky,Klaudia Adamowicz,Gary D. Bader,David Blumenthal,Jing Chen,Maria L. Elkjaer,Markus Hoffmann,Igor Jurisica,Max Kotlyar,Olga Lazareva,Hagai Levi,Markus List,Sebastian Lobentanzer,Joseph Loscalzo,Noël Malod-Dognin,Q. Manz,Julian Matschinske,Mhaned Oubounyt,Alexander R. Pico,Rudolf T. Pillich,Dexter Pratt,Sepideh Sadegh,Julio Saez-Rodriguez,Gideon M. Shaked,Ron Shamir,Nico Trummer,Uğur Turhan,Rui-Sheng Wang,O. Zolotareva,Jan Baumbach +31 more
TL;DR: Drugst.One as discussed by the authors is a platform that assists specialized computational medicine tools in becoming user-friendly, web-based utilities for drug repurposing, turning any system biology software into an interactive web tool for modeling and analyzing complex protein-drug-disease networks.
7
Network medicine-based epistasis detection in complex diseases: ready for quantum computing
Markus Hoffmann,Julian M. Poschenrieder,Sylvie Baier,Amelie Fitz,Andreas Maier,Michael Hartung,Christian Hoffmann,Nico Trummer,Klaudia Adamowicz,Mario Picciani,Evelyn Scheibling,Maximilian V. Harl,Ingmar Lesch,Hunor Frey,Simon Kayser,Paul Wissenberg,Leon Schwartz,Leon Hafner,Aakriti Acharya,L. Hackl,Gordon Grabert,Sung-Gwon Lee,Gyuhyeok Cho,Matthew Cloward,Jakub Jankowski,Hye Kyung Lee,Olga Tsoy,Nina Wenke,Anders Gorm Pedersen,Klaus Bønnelykke,Anthony Mandarino,Federico Melograna,Laura Schulz,H´ector Climente-Gonz´alez,Mathias Wilhelm,Luigi Iapichino,Lars Wienbrandt,David Ellinghaus,Kristel Van Steen,Michele Grossi,Priscilla A. Furth,Lothar Hennighausen,Alessandra Di Pierro,Jan Baumbach,Tim Kacprowski,Markus List,David B. Blumenthal +46 more
TL;DR: NeEDL is the first application that demonstrates the potential of seamlessly integrated quantum computing techniques to accelerate biomedical research and detects higher-order EIs with unprecedented statistical and biological evidence, yielding unique insights into polygenic diseases and providing a basis for the development of improved risk scores and combination therapies.
2
TF-Prioritizer: a Java pipeline to prioritize condition-specific transcription factors
Markus Hoffmann,Nico Trummer,Leon Schwartz,Jakub Jankowski,Hye Kyung Lee,Lina-Liv Willruth,Olga Lazareva,Kevin Yuan,Nina Baumgarten,Florian Schmidt,Jan Baumbach,Marcel H. Schulz,David Blumenthal,Lothar Hennighausen,Markus List +14 more
TL;DR: TF-Prioritizer accepts ChIP-seq and RNA-seq data, as input and suggests TFs with differential activity, thus offering an understanding of genome-wide gene regulation, potential pathogenesis, and therapeutic targets in biomedical research.
circRNA-sponging: a pipeline for extensive analysis of circRNA expression and their role in miRNA sponging
Markus Hoffmann,Leon Schwartz,Octavia-Andreea Ciora,Nico Trummer,Lina-Liv Willruth,Jakub Jankowski,Hye Kyung Lee,Jan Baumbach,Priscilla A. Furth,Lothar Hennighausen,Markus List +10 more
TL;DR: The circRNA-sponging pipeline as mentioned in this paper identifies circRNAs via backplicing junctions detected in RNA-seq data, quantifies their expression values in relation to their linear counterparts spliced from the same gene, performs differential expression analysis, identifies and quantifies miRNA expression from miRNA-sequencing (miRNA-seq) data, predicts miRNA binding sites on circRNA, systematically investigates potential circRN-miRNA sponging events, creates a network of competing endogenous RNAs, and identifies potential circRNA biomarkers.
Blood transcriptomics analysis offers insights into variant-specific immune response to SARS-CoV-2
Markus Hoffmann,Lina-Liv Willruth,Alexander Dietrich,Hye Kyung Lee,Ludwig Knabl,Nico Trummer,Jan Baumbach,Priscilla A. Furth,Lothar Hennighausen,Markus List +9 more
TL;DR: This study reveals that computational cell-type deconvolution and BCR/TCR methods using bulk RNA-seq analyses can supplement missing CBC data and offer insights into immune responses, disease severity, and pathogen-specific immunity, all achievable with a sequencing depth of 10 million reads per sample.